BRCA1 and breast cancer: Due to tumor heterogeneity and presence of several subtypes, TNBC is of particular concern; it is clinically aggressive compared to other breast cancers, has poor prognosis on overall survival (OS) and disease-free survival (DFS), lacks specific target for therapeutic intervention, and overlaps with BRCA1-associated breast cancers.